A Randomized Phase II Clinical Trial of an Adenovirus-Mediated Endostatin Gene (E10A) Combined With Cisplatin and Paclitaxel in Patients With Head and Neck Cancer.

Trial Profile

A Randomized Phase II Clinical Trial of an Adenovirus-Mediated Endostatin Gene (E10A) Combined With Cisplatin and Paclitaxel in Patients With Head and Neck Cancer.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Endostatin gene therapy (Primary) ; Cisplatin; Paclitaxel
  • Indications Head and neck cancer; Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2010 Preliminary results from 68 patients presented at 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
    • 05 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top